| 000 | 00922 a2200277 4500 | ||
|---|---|---|---|
| 005 | 20250517155629.0 | ||
| 264 | 0 | _c20180306 | |
| 008 | 201803s 0 0 eng d | ||
| 022 | _a2159-8290 | ||
| 024 | 7 |
_a10.1158/2159-8290.CD-17-0380 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSchram, Alison M | |
| 245 | 0 | 0 |
_aQuantifying the Benefits of Genome-Driven Oncology. _h[electronic resource] |
| 260 |
_bCancer discovery _c06 2017 |
||
| 300 |
_a552-554 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Comment | ||
| 650 | 0 | 4 | _aGenome, Human |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMedical Oncology |
| 650 | 0 | 4 | _aMolecular Targeted Therapy |
| 650 | 0 | 4 |
_aNeoplasms _xgenetics |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aHyman, David M | |
| 773 | 0 |
_tCancer discovery _gvol. 7 _gno. 6 _gp. 552-554 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1158/2159-8290.CD-17-0380 _zAvailable from publisher's website |
| 999 |
_c27241473 _d27241473 |
||